Sandbox skin2: Difference between revisions

Jump to navigation Jump to search
Line 32: Line 32:


* Impetigo, adult
* Impetigo, adult
:* Empiric antimicrobial therapy (methicillin-susceptible Staphylococcus aureus and β-hemolytic Streptococcus)
:* Empiric antimicrobial therapy (covering methicillin-susceptible Staphylococcus aureus and β-hemolytic Streptococcus)
::* '''Limited number of lesions'''
::* '''Limited number of lesions'''
:::* Preferred regimen: [[Mupirocin]] topically bid for 5 days {{or}} [[Retapamulin]] topically bid for 5 days
:::* Preferred regimen: [[Mupirocin]] topically bid for 5 days {{or}} [[Retapamulin]] topically bid for 5 days

Revision as of 02:10, 30 May 2015

Acne vulgaris

Acne rosacea

Anthrax, cutaneous

Bacillary angiomatosis

Bite wounds

Carbuncle

Cat scratch disease

Cellulitis

Ecthyma

Erysipelas

Erysipeloid

Erythrasma

Furuncle

Gas gangrene

Glanders

Impetigo

  • Impetigo, adult
  • Empiric antimicrobial therapy (covering methicillin-susceptible Staphylococcus aureus and β-hemolytic Streptococcus)
  • Limited number of lesions
  • Numerous lesions or outbreaks of post streptococcal glomerulonephritis
  • Culture-directed antimicrobial therapy
  • Streptococcus alone
  • Methicillin-resistant Staphylococcus aureus


  • Ecthyma
  • Empiric therapy Oral 7 days (MSSA)

Lyme disease, cutaneous

Mastitis

Necrotizing fasciitis

Pilonidal cyst

Pyomyositis

Seborrheic dermatitis

Surgical site infections

Vascular insufficieny ulcer

Vibrio infection

Wound infection

Yaws